GLOBAL MEDICAL REIT INC (GMRE) Stock Fundamental Analysis
NYSE:GMRE - US37954A2042 - REIT
7.33 USD
+0.33 (+4.71%)
7.37 USD
+0.04 (+0.55%)
Overall GMRE gets a fundamental rating of 2 out of 10. We evaluated GMRE against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of GMRE have multiple concerns. While showing a medium growth rate, GMRE is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
GMRE had positive earnings in the past year.
GMRE had a positive operating cash flow in the past year.
Of the past 5 years GMRE 4 years were profitable.
Each year in the past 5 years GMRE had a positive operating cash flow.
1.2 Ratios
GMRE has a Return On Assets (0.34%) which is comparable to the rest of the industry.
With a Return On Equity value of 0.89%, GMRE perfoms like the industry average, outperforming 46.51% of the companies in the same industry.
The Return On Invested Capital of GMRE (2.14%) is comparable to the rest of the industry.
GMRE had an Average Return On Invested Capital over the past 3 years of 2.29%. This is in line with the industry average of 3.07%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.34% | ||
| ROE | 0.89% | ||
| ROIC | 2.14% |
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
1.3 Margins
GMRE has a Profit Margin (3.15%) which is comparable to the rest of the industry.
GMRE's Profit Margin has declined in the last couple of years.
GMRE has a Operating Margin (23.55%) which is in line with its industry peers.
GMRE's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.55% | ||
| PM (TTM) | 3.15% | ||
| GM | N/A |
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GMRE is destroying value.
GMRE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GMRE has been increased compared to 5 years ago.
GMRE has a worse debt/assets ratio than last year.
2.2 Solvency
GMRE has an Altman-Z score of 0.18. This is a bad value and indicates that GMRE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.18, GMRE is not doing good in the industry: 67.44% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.39 is on the high side and indicates that GMRE has dependencies on debt financing.
With a Debt to Equity ratio value of 1.39, GMRE perfoms like the industry average, outperforming 45.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.18 |
ROIC/WACC0.33
WACC6.56%
2.3 Liquidity
A Current Ratio of 0.24 indicates that GMRE may have some problems paying its short term obligations.
GMRE has a worse Current ratio (0.24) than 89.92% of its industry peers.
GMRE has a Quick Ratio of 0.24. This is a bad value and indicates that GMRE is not financially healthy enough and could expect problems in meeting its short term obligations.
GMRE has a Quick ratio of 0.24. This is amonst the worse of the industry: GMRE underperforms 89.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.24 | ||
| Quick Ratio | 0.24 |
3. Growth
3.1 Past
The earnings per share for GMRE have decreased strongly by -82.61% in the last year.
Measured over the past years, GMRE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.74% on average per year.
Looking at the last year, GMRE shows a small growth in Revenue. The Revenue has grown by 3.03% in the last year.
The Revenue has been growing by 14.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-82.61%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%80%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%10.89%
3.2 Future
The Earnings Per Share is expected to grow by 23.08% on average over the next years. This is a very strong growth
GMRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.61% yearly.
EPS Next Y70.01%
EPS Next 2Y33.6%
EPS Next 3Y18.35%
EPS Next 5Y23.08%
Revenue Next Year5.93%
Revenue Next 2Y4.98%
Revenue Next 3Y5.52%
Revenue Next 5Y3.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 73.30, which means the current valuation is very expensive for GMRE.
Compared to the rest of the industry, the Price/Earnings ratio of GMRE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.24, GMRE is valued quite expensively.
A Price/Forward Earnings ratio of 102.66 indicates a quite expensive valuation of GMRE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GMRE is on the same level as its industry peers.
GMRE is valuated expensively when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.3 | ||
| Fwd PE | 102.66 |
4.2 Price Multiples
GMRE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GMRE is cheaper than 61.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.42 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as GMRE's earnings are expected to grow with 18.35% in the coming years.
PEG (NY)1.05
PEG (5Y)N/A
EPS Next 2Y33.6%
EPS Next 3Y18.35%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 8.57%, GMRE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.36, GMRE pays a better dividend. On top of this GMRE pays more dividend than 82.17% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, GMRE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.57% |
5.2 History
The dividend of GMRE decreases each year by -0.24%.
GMRE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of GMRE decreased in the last 3 years.
Dividend Growth(5Y)-0.24%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
GMRE pays out 1484.61% of its income as dividend. This is not a sustainable payout ratio.
DP1484.61%
EPS Next 2Y33.6%
EPS Next 3Y18.35%
7.33
+0.33 (+4.71%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners69.9%
Inst Owner Change1.42%
Ins Owners0.33%
Ins Owner Change2.27%
Market Cap490.23M
Analysts78.75
Price Target9.15 (24.83%)
Short Float %3.96%
Short Ratio3.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.57% |
Yearly Dividend0.99
Dividend Growth(5Y)-0.24%
DP1484.61%
Div Incr Years0
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.31%
Min EPS beat(2)-132.68%
Max EPS beat(2)135.29%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.58%
Min Revenue beat(2)-4.08%
Max Revenue beat(2)5.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-4.08%
Max Revenue beat(4)5.24%
Revenue beat(8)2
Avg Revenue beat(8)-2.01%
Revenue beat(12)2
Avg Revenue beat(12)-1.82%
Revenue beat(16)4
Avg Revenue beat(16)-1.51%
PT rev (1m)-1.37%
PT rev (3m)-14.33%
EPS NQ rev (1m)-69.23%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)-42.53%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)6.92%
Revenue NQ rev (3m)4.66%
Revenue NY rev (1m)3.08%
Revenue NY rev (3m)3.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.3 | ||
| Fwd PE | 102.66 | ||
| P/S | 3.45 | ||
| P/FCF | N/A | ||
| P/OCF | 6.88 | ||
| P/B | 0.97 | ||
| P/tB | 1.11 | ||
| EV/EBITDA | 13.42 |
EPS(TTM)0.1
EY1.36%
EPS(NY)0.07
Fwd EY0.97%
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)1.07
OCFY14.53%
SpS2.12
BVpS7.52
TBVpS6.62
PEG (NY)1.05
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.34% | ||
| ROE | 0.89% | ||
| ROCE | 2.71% | ||
| ROIC | 2.14% | ||
| ROICexc | 2.15% | ||
| ROICexgc | 2.31% | ||
| OM | 23.55% | ||
| PM (TTM) | 3.15% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
ROICexc(3y)2.3%
ROICexc(5y)2.11%
ROICexgc(3y)2.52%
ROICexgc(5y)2.3%
ROCE(3y)2.9%
ROCE(5y)2.66%
ROICexcg growth 3Y-3.14%
ROICexcg growth 5Y-2.71%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y-2.82%
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.85 | ||
| Cap/Depr | 295.75% | ||
| Cap/Sales | 116.01% | ||
| Interest Coverage | 1.18 | ||
| Cash Conversion | 79.91% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.24 | ||
| Quick Ratio | 0.24 | ||
| Altman-Z | 0.18 |
F-Score5
WACC6.56%
ROIC/WACC0.33
Cap/Depr(3y)155.62%
Cap/Depr(5y)302.85%
Cap/Sales(3y)63.21%
Cap/Sales(5y)120.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.61%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%80%
EPS Next Y70.01%
EPS Next 2Y33.6%
EPS Next 3Y18.35%
EPS Next 5Y23.08%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%10.89%
Revenue Next Year5.93%
Revenue Next 2Y4.98%
Revenue Next 3Y5.52%
Revenue Next 5Y3.61%
EBIT growth 1Y-6.43%
EBIT growth 3Y-3.87%
EBIT growth 5Y3.82%
EBIT Next Year177.64%
EBIT Next 3Y44.02%
EBIT Next 5Y31.78%
FCF growth 1Y-792.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.37%
OCF growth 3Y0.52%
OCF growth 5Y13.97%